About BioAsia

Focus

Biotechnology being an emerging industry, game-changing strategies and relevant application of the knowledge-intelligence resource pool, drive the process of growth. BioAsia seeks to enhance, enrich and encourage newer innovations, path-breaking discoveries and effective solutions in the industry by offering a vibrant global platform for convergence of the key stakeholders - Biotech & Biopharma Companies, research institutions, investors, service providers, policy makers, regulators and analysts.

Organizers

Genome Valley

Genome Valley, spread over 600 sq. kms. in the vicinity of Hyderabad (the Cyber City of India) is India's first world-class biotech cluster for biotech research, training, collaboration and manufacturing activities. With an established presence of several global and Indian biotechnology companies, globally renowned research institutions, and best-in-class supporting specialized infrastructure, today Genome Valley is the largest and most vibrant biotech cluster in the country...

	Archives
	Gallery
	Publications

Industry Speak

Shri N Kiran Kumar Reddy, Hon'ble Chief Minister of Andhra Pradesh

Biotech companies have a crucial role in the society and will have to keep the quality ...

Dr. (Smt.) J. Geeta Reddy, the Hon'ble Minister for Major Industries, Sugar, Commerce & Export Promotion, Govt. Of Andhra Pradesh

BioAsia has been successful in significantly contributing towards ...

Roopesh Bhargava, Director - Sales & Marketing, Sanofi Pasteur India (Pvt) Ltd., Mumbai

"It was indeed a pleasure attending the BioAsia 2012 at Hyderabad. It was a very well thought off coordinated effort to put such a conference. My personal compliments to the team. The Agenda and the subject was very well chosen"

Dr. Shreemanta K Parida, CEO, Vaccine Grand Challenge Program, Dept of Biotechnology, Ministry of Science & Technology, Govt. of India

I commend BioAsia2012 organisers for making an effort to bring various stakeholders around the table in a breakfast meeting with Seth Berkley ...

Dr. Harish Iyer, CEO, Shantha Biotech, Hyderabad

"This was an excellent meeting with topics discussed being clearly relevant to vaccines and expanding use for improvement of public health"

Mr. Manni Kantipudi, Chief Executive Officer, GVK Biosciences

"The BioAsia 2012 was well organized, had good speakers and was well attended. The focus on CROs was important for HYDERABAD to project".

Dr. K V Balasubramaniam, Managing Director, Indian Immunologicals Ltd.

"More professionally conducted this time with better industry participation"

Mr. Karikal Valaven, IAS, Convener, BioAsia 2012

The precise number of registered delegates for the event was 598; in addition over 450 visitors also thronged the three-day global bio-business event ...

Dr. Krishna Ella, Chairman and Managing Director, Bharat Biotech International Ltd.

Over the years, BioAsia has become an industry oriented event while the Bangalore India Bio event has remained research oriented ...

Dr. Richard Connell, Vice President and Head of Asia Research, Pfizer, Shanghai

"There were some interesting discussions and it was good to meet business partners at the location. The logistics (layout of rooms, food, location) were all very comfortable."

Mr. Sai D. Prasad, VP – Business Development, Bharat Biotech International Ltd.

"BioAsia 2012 was well organized."

BioAsia Organizers

Click on logo...

0408rdc.com

For optimal viewing of this website, recommended browsers are Internet Explorer 7 and above versions, Chrome, Firefox and Safari
This website can be best viewed in 1152 x 864 screen resolution.